Myopia Profile

Cooper Vision

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?

Cooper Vision myopia management products

Myopia management products listed by Myopia Profile have been specifically designed for myopia control or myopia management in children, and have some form of regulatory approval or marking for this form of use. They also have randomized controlled trial research data supporting their efficacy, unless otherwise noted. It is up to the individual eye care practitioner to be aware of regulatory requirements for prescribing in their country of practice, and also be aware that not all products are available in all countries.

MiSight® 1 day

MiSight® 1 day is safe, well-tolerated, and has the longest and most robust data available on its safety and efficacy of any soft contact lens option for myopia control. It can be considered a first-line treatment for myopia correction and control. It is also the first and currently only myopia control intervention which has received United States FDA indication for myopia control. The MiSight® 1 day dual-focus contact lens has been demonstrated in two randomized clinical trials (two years' and three years' duration) to have a high safety profile, be effective, and well accepted by myopic children. It has the longest dataset available of any myopia controlling soft contact lens, with clinical study results published for up to six years and reported for up to seven years.

More about MiSight® 1 day

Other relevant products

The following product(s) have not been specifically designed for myopia control and/or do not have regulatory approval for the same, but are listed by Myopia Profile as they have randomized controlled trial research data supporting their efficacy for myopia management. Suitability for prescribing these treatments will depend on your country and regulatory requirements of practice, and also be aware that not all products are available in all countries.

Biofinity

This lens designs was originally designed for presbyopia and does not have any regulatory approvals for myopia control in children. When considered for off-label prescribing, the Biofinity® Multifocal lenses have a wide range of parameters and can be an option for children that don't fit or whose prescription is too high for other soft contact lens options. One randomized controlled trial showed efficacy and tolerance of children wearing the +2.50 D (centre-distance) design for slowing myopia progression. The +1.50 D design was also trialled and was found to not be effective. Another study with an historical control group showed efficacy for the Proclear® Multifocal +2.00 D (centre-distance) design. 

A toric design is available, but it has not been studied for its efficacy for control of myopia in the presence of astigmatism. Monthly replacement contact lenses can be suitable for individuals who understand and can demonstrate good contact lens hygiene.  

More about Biofinity

Cooper Vision resources

Myopia Simulator: The next best thing

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Learn More about Myopia Simulator: The next best thing
An unhandled exception has occurred. See browser dev tools for details. Reload 🗙